About
Activity
-
Aan het al het moois komt een einde👋🏻 Waar ik vorig jaar voor 3 maanden instapte bij Judith Zwaan RC en Patricia Nelen stap ik zelf 11 maanden…
Aan het al het moois komt een einde👋🏻 Waar ik vorig jaar voor 3 maanden instapte bij Judith Zwaan RC en Patricia Nelen stap ik zelf 11 maanden…
Liked by Alexander Goemans
-
We're thrilled to share that Peter Ohnemus, CEO of dacadoo has been invited to speak at the Tech Tour Growth Health! This event, happening on…
We're thrilled to share that Peter Ohnemus, CEO of dacadoo has been invited to speak at the Tech Tour Growth Health! This event, happening on…
Liked by Alexander Goemans
-
Very happy to share my promotion to partner!! I am part of a fantastic team full of inspiring people and excited to continue the journey at Ysios for…
Very happy to share my promotion to partner!! I am part of a fantastic team full of inspiring people and excited to continue the journey at Ysios for…
Liked by Alexander Goemans
Experience & Education
Honors & Awards
-
Shortlisted for the 2017 Bracken Bower Prize
McKinsey & The Financial Times
More activity by Alexander
-
We are pleased to announce the appointment of Shawn M. Gage, PA-C as our new Vice President of US Clinical Affairs at Xeltis. Shawn brings nearly…
We are pleased to announce the appointment of Shawn M. Gage, PA-C as our new Vice President of US Clinical Affairs at Xeltis. Shawn brings nearly…
Liked by Alexander Goemans
-
The top 10 most-read Vascular News stories in June featured two US FDA investigational device exemption (IDE) approvals and a series of highlights…
The top 10 most-read Vascular News stories in June featured two US FDA investigational device exemption (IDE) approvals and a series of highlights…
Liked by Alexander Goemans
-
Today I climbed a tree. It was glorious. I almost didn't go outside, because... ... I had too much work to do. ... too many e-mails to respond…
Today I climbed a tree. It was glorious. I almost didn't go outside, because... ... I had too much work to do. ... too many e-mails to respond…
Liked by Alexander Goemans
-
✨ Wat een fantastische dag bij het Rubicon Summer Festival! ✨ Gisteren mochten we met Grow With The Flow 2 workshops verzorgen op het Rubicon Summer…
✨ Wat een fantastische dag bij het Rubicon Summer Festival! ✨ Gisteren mochten we met Grow With The Flow 2 workshops verzorgen op het Rubicon Summer…
Liked by Alexander Goemans
-
Graduated this weekend from Antwerp Management School with an Executive MBA. A backpack full of learnings, international trips and new inspiration…
Graduated this weekend from Antwerp Management School with an Executive MBA. A backpack full of learnings, international trips and new inspiration…
Liked by Alexander Goemans
-
𝐋𝐮𝐧𝐜𝐡 𝐥𝐞𝐜𝐭𝐮𝐫𝐞 𝐗𝐞𝐥𝐭𝐢𝐬 On June 5th we organized a lunch lecture together with Xeltis at Eindhoven University of Technology. Xeltis is…
𝐋𝐮𝐧𝐜𝐡 𝐥𝐞𝐜𝐭𝐮𝐫𝐞 𝐗𝐞𝐥𝐭𝐢𝐬 On June 5th we organized a lunch lecture together with Xeltis at Eindhoven University of Technology. Xeltis is…
Liked by Alexander Goemans
-
Truly exciting times ahead… I am glad to announce that I have joined the Heylen Group as a Senior Investment Manager. Being surrounded by…
Truly exciting times ahead… I am glad to announce that I have joined the Heylen Group as a Senior Investment Manager. Being surrounded by…
Liked by Alexander Goemans
-
Been looking forward to this announcement ... Xeltis receive IDE approval from the FDA for their haemodialysis vascular access conduit. Having…
Been looking forward to this announcement ... Xeltis receive IDE approval from the FDA for their haemodialysis vascular access conduit. Having…
Liked by Alexander Goemans
-
#portfolionews I Our portfolio company Xeltis has received Investigational Device Exemption (IDE) approval from FDA - La Administración de Alimentos…
#portfolionews I Our portfolio company Xeltis has received Investigational Device Exemption (IDE) approval from FDA - La Administración de Alimentos…
Liked by Alexander Goemans
-
Xeltis has recently announced that it has gained approval from the FDA for an investigational device exemption (IDE) submission to begin enrolling…
Xeltis has recently announced that it has gained approval from the FDA for an investigational device exemption (IDE) submission to begin enrolling…
Liked by Alexander Goemans
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Alexander Goemans
-
Alexander Goemans
Systemvetenskap, Lunds Universitet || Försäkringsrådgivare, Trygg-Hansa
-
Alexander Goemans
O'Briens Off licence at Trinity College Dublin
-
Alex Goemans
Business Consultant, Leadership Development, Corporate Wellness
-
Alex Goemans
AED group member- Synthesizer Expert
6 others named Alexander Goemans are on LinkedIn
See others named Alexander Goemans